MPXV A29L (AA 2-110) Antikörper

Produktnummer ABIN7572177

Produktdetails

Target: MPXV A29L

Bindungsspezifität: AA 2-110

Reaktivität: Mpox Virus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Verwendungszweck: Anti-Monkeypox virus/MPXV A29L Polyclonal Antibody

Aufreinigung: Antigen affinity purification.

Immunogen: E. coli - derived recombinant Monkeypox virus/MPXV A29L (Asp2-Glu110).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C,-80 °C

Informationen zur Lagerung: Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.

Referenzen

Ye, Zhou, Guo, Zhang, Wang, Liu, Zhou, Xie, Li, Gong, Zhang, Chuai, Chiu: "Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus." in: Cell reports, Vol. 43, Issue 6, pp. 114269, (2024) (PubMed).

Zhou, Ye, Yang, Li, Zhang, Wang, Chen, Hu, Zhang, Liu, Gong, Chuai, Wang, Chiu: "Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 32, Issue 6, pp. 1779-1789, (2024) (PubMed).

Antigendetails

Target: MPXV A29L

Hintergrund: A29L, Monkeypox virus (MPXV),A29